Pure Global AI
UMIN000052339Not yet recruiting

Single-center study of MR-guided accelerated partial breast irradiation for low-risk breast cancer

National Cancer CenterPhase 2University Hospital Medical Information Networkother
VerifiedUniversity Hospital Medical Information Network
Study focus
Disease/Condition
breast cancer
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
National Cancer Center
Location
Japan
Timeline & enrollment
Phase
Phase 2
Start date
Oct 15, 2023
End date
N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedMalignant neoplasm: Breast, unspecifiedOther carcinoma in situ of breast
Data source
Registry
University Hospital Medical Information Network
Trial ID
UMIN000052339
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for UMIN000052339 through Pure Global AI's free database. This Phase 2 trial is sponsored by National Cancer Center and is currently Not yet recruiting. The study focuses on breast cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.